These personality types are most likely to cheat using AI
The paper, published in the journal BMC Psychology by Jinyi Song of South Korea's Chodang University and Shuyan Liu of Baekseok University, surveyed 504 college-level Chinese art students. Researchers assessed traits like narcissism, psychopathy, and Machiavellianism, all of which are collectively known as the 'Dark Triad.' They found that students who scored highly on these traits were significantly more likely to use AI tools like ChatGPT and Midjourney to complete their assignments.
Why? According to PsyPost, narcissists may cheat to bolster their self-image or gain recognition, while those high in Machiavellianism may view AI as a way to gain an edge over their peers. Psychopathy, meanwhile, is associated with impulsivity and a lack of remorse.
The study also found that students with higher dark trait scores were more likely to pass off AI-generated work as their own. These same students were more anxious about academic performance and more prone to procrastination—factors that made them more likely to rely on AI to finish their assignments.
Researchers also examined materialism. Students who scored higher in materialistic values, or who were driven by external rewards and praise, were similarly more likely to misuse AI.
While those surveyed face a perfect storm of competition, pressure to produce original creative work, and the increasing presence of generative AI in their field, the ChatGPT dilemma now extends across creative industries, academia, and beyond.
Thanks to artificial intelligence, the temptation to turn to AI—whether for homework or even just writing a text—has never been more pervasive. Next time you reach for ChatGPT, consider what it might reveal about you.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Wayvia Ushers in New Era of AI-Driven Omnicommerce with Commerce Intelligence Engine
Formerly known as PriceSpider, Wayvia harnesses over 20 years of shopper and retail intelligence to fuel the next generation of AI-driven commerce IRVINE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Wayvia, the omnicommerce enablement leader formerly known as PriceSpider, debuts today with a bold product vision built for a new era of commerce where AI, data and intelligent agents shape the path to purchase. The launch signals a new chapter for the company, with an expanded product strategy, deeper AI capabilities and more powerful media and data solutions designed to help brands drive revenue across every channel. As part of the launch, the company is introducing Wayvia MCP (Model Context Protocol), an intelligent AI infrastructure built on more than two decades of shopper data, pricing intelligence and market behavior. Purpose-built as an AI-native commerce intelligence engine, Wayvia MCP eliminates the need for dashboards, SQL or manual queries by enabling natural language access to live product and market data. It is the first enterprise-grade solution to give AI agents direct, secure access to commerce data through a native implementation of the Model Context Protocol. 'Wayvia reflects our belief that the future of commerce will be shaped as much by intelligent systems as by human decisions,' said Anthony Ferry, CEO of Wayvia. 'As AI agents and algorithms increasingly influence how products are discovered and purchased, brands need more than traditional dashboards - they need infrastructure built for AI. And Wayvia MCP is our commitment to giving brands the tools to compete, adapt and lead in this new era of commerce.' Commerce is no longer linear. Algorithms determine what products get seen, AI agents shape consumer choices and real-time pricing and inventory data drive conversions. Wayvia equips brands with the intelligence and tools to compete in this dynamic environment. With shopper and retail intelligence from any channel, brands have more insight into their shoppers' behaviors while improving the path to purchase, from offsite, onsite and agentic commerce and beyond. Wayvia's product strategy centers on building a smarter path to revenue, giving brands the visibility, tools and intelligence they need to compete across an increasingly complex retail landscape. Core areas include: Omnicommerce Data: Activate omnicommerce path and audience data to power analytics, optimize shopping journeys and enable AI solutions. Shoppable Media: Connect shoppable media and shopping agents from any channel to retailer conversions. Retail Intelligence: Compete with product-level price, availability, channel performance and AI-powered decisions. Founded nearly two decades ago as a price-comparison tool, PriceSpider was an early pioneer of 'Where to Buy' technology and has since evolved into a full-funnel omnicommerce performance platform built to meet the growing demands of modern brands. The launch of Wayvia marks the next chapter in that evolution, reflecting the company's expanded capabilities and vision for the future of AI-driven commerce. Wayvia represents the next evolution of PriceSpider, combining its proven foundation with smarter, more adaptive technology and deeper insight into real-time pricing, product availability and shopper behavior. Wayvia preserves the core elements that built its credibility, including a stable leadership team, trusted solutions, strong partnerships and a deep commitment to enabling brand growth at a global scale. To learn more about Wayvia, please visit About Wayvia: Wayvia is the global leader in omnicommerce data and brand enablement. By connecting shopper and retail intelligence across every channel, brands gain deeper insight into consumer behavior and unlock new opportunities to improve the path to purchase, whether through offsite media, onsite experiences or agentic commerce. Backed by the world's largest network of retailer and media partnerships, Wayvia offers brands the retail intelligence to power analytics, optimize shopping journeys and enable AI solutions. For more information, please visit to learn more. Media Contact For Wayvia:SamsonPRwayvia@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 minutes ago
- Yahoo
IBM falls most since 2021 after posting tepid software sales
(Bloomberg) — Shares of International Business Machines Corp. (IBM) fell the most in four and a half years after the company reported weaker-than-expected sales in its closely watched software segment, disappointing investors who have grown increasingly optimistic about the business. Second-quarter software unit sales increased 10% to $7.39 billion, the company said in a statement Wednesday, slightly below analysts' average estimate of $7.49 billion. The company's consulting business, which has been experiencing a growth slump, generated a revenue bump of 3% to $5.31 billion. Investors have been enthusiastic about IBM's software business and the potential for future growth from artificial intelligence tools and quantum computing. The company's management has heralded software and services as the path to rejuvenation since the 1990s. However, only recently under Chief Executive Officer Arvind Krishna has the approach really begun to materialize, with software now more than 40% of the company's annual revenue. Bookings for the AI business have exceeded $7.5 billion since mid-2023, the Armonk, New York-based company said. That is up from the $6 billion IBM disclosed during its last quarterly earnings report in April. About 80% of the bookings come from the consulting unit, with the rest from software. The shares fell as much as 10% after markets opened in New York on Thursday, their biggest intraday decline since Jan. 22, 2021 The stock had been up 28% this year through Wednesday's close, outpacing many technology peers. Overall, revenue increased 8% to $17 billion in the period ended June 30, the company said Wednesday in a statement. Analysts, on average, estimated $16.6 billion. Much of that performance was due to Big Blue's infrastructure unit. Sales in that division gained 14% to $4.14 billion, beating the $3.66 billion anticipated by Wall Street. This is the strongest initial launch of a mainframe product in IBM's history, Chief Financial Officer Jim Kavanaugh said in an interview. Demand is driven by large enterprises, particularly in the finance and retail industries, he said. Despite the top line strength, investors are likely to question how durable IBM's software growth is in the second half of the year, wrote Amit Daryanani, an analyst at Evercore ISI. On a call with analysts after the results were released, Kavanaugh said that Red Hat software sales should continue growing in the mid-teens. The group, which was acquired in 2019, posted 16% growth in the second quarter. Profit, excluding some items, was $2.80 per share, compared with the average estimate of $2.62. Kavanaugh said IBM is targeting steeper cost reductions, which is helping improve margins. Technology vendors who sell to the US government have been anxious about the impact of cost cuts under the Trump administration. Kavanaugh said that some of IBM's federal contracts that were previously paused have been reinstated and no new contracts have been affected. IBM maintained its annual sales forecast of at least 5% growth in constant currency. Free cash flow is projected to exceed $13.5 billion, in line with analysts' estimates. (Updates with Thursday trading starting in the first paragraph.) ©2025 Bloomberg L.P.
Business Wire
19 minutes ago
- Business Wire
Elation Survey Finds Nearly 40% of Primary Care Physicians Use AI-powered Tools for Daily Clinical Documentation
SAN FRANCISCO--(BUSINESS WIRE)-- Elation Health, the clinical-first technology company powering innovation in primary care, today announced the results of its latest AI in Primary Care survey of 291 primary care physicians, focused on the current sentiments, adoption patterns, critical concerns (defects), key behavioral insights (learnings), and explicit user desires (requests) regarding the integration of Artificial Intelligence (AI) in primary care workflows. The analysis reveals 39.3% use AI-powered tools daily, specifically for clinical documentation. The survey also revealed that clinicians have a clear hierarchy of needs when it comes to AI, with fundamental performance factors at the top of that hierarchy. With 59% of respondents in agreement, accuracy and reliability ranked as the most important factor when evaluating AI tools. Seamless workflow integration and ease of use followed at 22%, while efficiency and time savings (ROI) came in at 13%, and cost affordability at 6% (see Table 1). Table 1: Most Important Factors in Choosing an AI Tool 'Our survey confirms what we already suspected: clinicians are cautiously optimistic about AI's potential, but they're looking for thoughtful, trustworthy, affordable solutions that truly fit the realities of primary care,' said Sara Pastoor, MD, MHA, FAAFP, and director of primary care advancement for Elation Health. 'At Elation, we're applying AI in ways that are context-aware, and fit naturally into clinical and operational workflows to enable high-quality care hand in hand with long-term financial success.' While the survey also affirmed the general attitude towards AI in clinical settings is predominantly positive, a notable segment remains neutral or skeptical. Although a combined 59% of respondents rate their sentiment as "Positive" or "Very Positive," 24% of respondents were 'Neutral' in their sentiments about AI. This sizable group appears to be open to AI advancements but may be likely waiting for clear evidence of its value, reliability, and ease of use before fully embracing it. These findings reinforce how Elation approaches research and development with Elation's Innovation Labs that leverage a dynamic, interactive product development and testing framework to allow it to work shoulder-to-shoulder with clinicians and staff through design cycles, usability testing, and continuous in-product feedback. This ensures Elation is developing AI in ways that clinicians trust and find valuable. Elation Health's clinical-first approach to AI is distinguished by continuous, hands-on collaboration with primary care clinicians throughout the Elation Labs development process. Every new AI capability is shaped directly by clinician feedback, gathered through design cycles, usability testing, and ongoing in-product input. Elation's iterative, transparent partnership with customers ensures that its AI features are clinically relevant, trustworthy, and seamlessly integrated into daily workflows, empowering clinicians while keeping the focus firmly on patient care. The survey was conducted with 291 independent primary care clinicians who are current Elation Health customers. For more on the results from Elation's State of AI in Primary Care Clinical Practice survey, visit here. To join Elation's product developers for a live, interactive webinar to explore how ethical, clinician-designed AI embedded within the EHR is transforming primary care by reducing burnout, improving care quality, and empowering both clinicians and patients: register here. About Elation Elation Health is the clinical-first AI platform for primary care success. Trusted by over 36,000 clinicians and 20 million patients, Elation's EHR and billing solutions combine proven clinical workflows with responsible, predictive AI - purpose built for primary care. The company's clinical-first approach puts physicians at the center, delivering trusted, transparent innovation that saves time and sustains meaningful patient relationships. Elation Health is recognized as Best in KLAS for its commitment to excellence in primary care technology. Learn more at and on LinkedIn.
